William Kelly
Director of Finance/CFO at VICARIOUS SURGICAL INC.
Net worth: 159 002 $ as of 2024-05-30
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Tony Hunt | M | 60 | 10 years | |
| Adam Sachs | M | 32 | 10 years | |
| Sammy Khalifa | M | 34 | 10 years | |
| Beverly A. Huss | F | 64 | 2 years | |
| Mark Kroll | M | 71 | 18 years | |
| Ric Fulop | M | 49 | 3 years | |
| Donald Tang | M | 41 | 3 years | |
| David Ho | M | 71 | 3 years | |
| Victoria Carr-Brendel | M | 60 | 1 years | |
| Barry Greene | M | - | 10 years | |
| John Mazzola | M | 61 | 2 years | |
| Emma Plouffe | F | - | - | |
| Michael Tricoli | M | - | - | |
| Kaitlyn Brosco | F | - | - | |
| Abby Mayo | F | - | - | |
| Jan Hartmann | M | - | 18 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Brian Concannon Concannon | M | 66 | 12 years | |
| Brad Nutter | M | 72 | - | |
| James L. Peterson | M | - | 18 years | |
| Susan Marie Hanlon | F | 56 | - | |
| Glenn L. Cooper | M | 71 | 11 years | |
| Philip Liang | M | 42 | 2 years | |
| Michael L. Hall | M | 62 | - | |
| John Cox | M | 61 | 7 years | |
| Dror Berman | M | 45 | 1 years | |
| David Styka | M | 65 | 3 years | |
| Jonathan Lieber | M | 54 | 2 years | |
| Samir Kaul | M | 50 | 1 years | |
| Pedro Granadillo | M | 77 | 15 years | |
| Alfred Lewis Goldberg | M | 81 | - | |
| Susan Bartlett Foote | F | 77 | 14 years | |
| Thomas McLain | M | 66 |
Exosome Diagnostics, Inc.
 Exosome Diagnostics, Inc. Medical/Nursing ServicesHealth Services Exosome Diagnostics, Inc. develops and commercializes biofluid-based diagnostics to deliver personalized precision healthcare that improves lives. Its novel exosome-based technology platform can yield comprehensive and dynamic molecular insights to transform how cancer and other serious diseases are detected, diagnosed, treated and monitored. The company was founded by Wayne D. Comper, Harvey J. Barnett and James R. McCullough and is headquartered in Waltham, MA. | 5 years |
| Michael A. Griffith | M | 66 | - | |
| Richard Meelia | M | 75 | 16 years | |
| June Morris | F | 75 | 2 years | |
| Lawrence C. Best | M | 75 | 11 years | |
| Joseph J. Forish | M | 71 | - | |
| Ronald Merriman | M | 79 | 12 years | |
| Chris Lindop | M | 67 | 9 years | |
| Sara Barrington | F | 57 |
Exosome Diagnostics, Inc.
Exosome Diagnostics, Inc. Medical/Nursing ServicesHealth Services Exosome Diagnostics, Inc. develops and commercializes biofluid-based diagnostics to deliver personalized precision healthcare that improves lives. Its novel exosome-based technology platform can yield comprehensive and dynamic molecular insights to transform how cancer and other serious diseases are detected, diagnosed, treated and monitored. The company was founded by Wayne D. Comper, Harvey J. Barnett and James R. McCullough and is headquartered in Waltham, MA. | 6 years |
| Daniel Zabrowski | M | 64 |
Exosome Diagnostics, Inc.
Exosome Diagnostics, Inc. Medical/Nursing ServicesHealth Services Exosome Diagnostics, Inc. develops and commercializes biofluid-based diagnostics to deliver personalized precision healthcare that improves lives. Its novel exosome-based technology platform can yield comprehensive and dynamic molecular insights to transform how cancer and other serious diseases are detected, diagnosed, treated and monitored. The company was founded by Wayne D. Comper, Harvey J. Barnett and James R. McCullough and is headquartered in Waltham, MA. | - |
| James McCullough | M | 56 |
Exosome Diagnostics, Inc.
Exosome Diagnostics, Inc. Medical/Nursing ServicesHealth Services Exosome Diagnostics, Inc. develops and commercializes biofluid-based diagnostics to deliver personalized precision healthcare that improves lives. Its novel exosome-based technology platform can yield comprehensive and dynamic molecular insights to transform how cancer and other serious diseases are detected, diagnosed, treated and monitored. The company was founded by Wayne D. Comper, Harvey J. Barnett and James R. McCullough and is headquartered in Waltham, MA. | 6 years |
| John Welch | M | - | 2 years | |
| Allen Latham | M | - | 32 years | |
| Lise Halpern | F | 65 | 6 years | |
| Vincent O'Neill | M | 55 |
Exosome Diagnostics, Inc.
Exosome Diagnostics, Inc. Medical/Nursing ServicesHealth Services Exosome Diagnostics, Inc. develops and commercializes biofluid-based diagnostics to deliver personalized precision healthcare that improves lives. Its novel exosome-based technology platform can yield comprehensive and dynamic molecular insights to transform how cancer and other serious diseases are detected, diagnosed, treated and monitored. The company was founded by Wayne D. Comper, Harvey J. Barnett and James R. McCullough and is headquartered in Waltham, MA. | 2 years |
| E. Jane Wilson | M | - | 2 years | |
| Robert Spurr | M | 62 | - | |
| Christopher McNulty | M | 47 | 3 years | |
| Thomas F. Lawlor | M | - | 1 years | |
| Timothy R. Surgenor | M | 64 | 4 years | |
| William Roche Still | M | - | - | |
| Ryoji Sakai | M | - | 13 years | |
| Hannah Mamuszka | F | 47 |
Exosome Diagnostics, Inc.
Exosome Diagnostics, Inc. Medical/Nursing ServicesHealth Services Exosome Diagnostics, Inc. develops and commercializes biofluid-based diagnostics to deliver personalized precision healthcare that improves lives. Its novel exosome-based technology platform can yield comprehensive and dynamic molecular insights to transform how cancer and other serious diseases are detected, diagnosed, treated and monitored. The company was founded by Wayne D. Comper, Harvey J. Barnett and James R. McCullough and is headquartered in Waltham, MA. | 5 years |
| Mikael Gordon | M | 69 | 5 years | |
| Tom Britton | M | - | - | |
| Timothy J. Coburn | M | - | - | |
| Howard Benjamin | M | 64 | - | |
| Debra L. Canner | F | 65 | 5 years | |
| Ronald A. Matricaria | M | 81 | - | |
| Joseph Slattery | M | 59 |
Exosome Diagnostics, Inc.
Exosome Diagnostics, Inc. Medical/Nursing ServicesHealth Services Exosome Diagnostics, Inc. develops and commercializes biofluid-based diagnostics to deliver personalized precision healthcare that improves lives. Its novel exosome-based technology platform can yield comprehensive and dynamic molecular insights to transform how cancer and other serious diseases are detected, diagnosed, treated and monitored. The company was founded by Wayne D. Comper, Harvey J. Barnett and James R. McCullough and is headquartered in Waltham, MA. | 5 years |
| Ronald J. Ryan | M | - | 8 years | |
| Elizabeth Cormier-May | F | 42 |
Exosome Diagnostics, Inc.
Exosome Diagnostics, Inc. Medical/Nursing ServicesHealth Services Exosome Diagnostics, Inc. develops and commercializes biofluid-based diagnostics to deliver personalized precision healthcare that improves lives. Its novel exosome-based technology platform can yield comprehensive and dynamic molecular insights to transform how cancer and other serious diseases are detected, diagnosed, treated and monitored. The company was founded by Wayne D. Comper, Harvey J. Barnett and James R. McCullough and is headquartered in Waltham, MA. | 3 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 63 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- William Kelly
- Personal Network
